The scientific commons in the marketplace: the industrialization of biomedical materials at the New England Enzyme Center, 1963–1980

Abstract

This paper investigates the industrialization of biomedical materials at the New England Enzyme Center (NEEC) from its establishment as a federally supported biochemical resource center in 1964 through its demise and refashioning into several commercial biotech companies in the late 1970s. It sets this history within the long‐standing debate on the proper relation between science and American economic and political traditions. The NEEC sought to embody two aims that stood in tension: academic independence in knowledge production and the market‐driven interests of the biomedical industry. A clash of values ensued, but built on a particular notion of independence: scientists pragmatically accepted the primacy of the market in the age of the ‘federal research economy.’ The question became how to carve out a space for science and scientific values in the market – an intellectual position that some legal and economic scholars have referred to as a scientific commons. Even so, industry executives came to see the idea of a scientific commons and public knowledge as obstructive to industrial innovation. This paper argues that, as seen through the case of the NEEC, the ascendancy of market values and attitudes in the 1970s played a critical role in reconfiguring the science‐industry relationship and in ‘industrializing’ the life sciences. As illustration of this change, I look at a commercial firm – Genzyme – born out of NEEC’s dissolution.